The only CAR-T cell therapy available for NHS patients in England and Wales for two distinct blood c...
Read moreOverall, the 2019 Voluntary Scheme has taken significant measures to reduce the time taken for patie...
Read moreNICE has recently developed the META tool, to support MedTech manufacturers in the identification of...
Read moreSince 29 July 2016 NICE) has employed a new fast-track appraisal process for oncology drugs.
Read moreNHS England’s cost-effectiveness watchdog, (NICE), issued a first draft document saying that it di...
Read moreThe new NICE oncology appraisal process aims to enable fast-track appraisals, allowing earlier acces...
Read moreEarlier this year, the UK government announced support for three new specialist centres capable of c...
Read moreSince 29th July 2016 the NICE appraisal process for oncology indications in England has been modifie...
Read moreThe European Commission (EC) has recently set out its draft proposal for adopting an EU-wide health...
Read moreIn June 2018, Remap Consulting had the pleasure of attending the annual National Institute of Health...
Read more